Improving Acromegaly: Let Your Patients Be Your Guide

Begin

Learning Objectives:

• Assess the pathophysiology and clinical symptomology associated with acromegaly to improve patient recognition and diagnosis
• Examine common comorbidities associated with acromegaly and the burden on patient quality of life despite endocrine control
• Review the latest clinical evidence regarding emerging treatments for the management of patients with acromegaly
• Evaluate the importance of communicating with patients regarding their disease state and realistic treatment expectations

Credits:
1.5 AMA PRA Category 1 Credits™
1.5 ABIM MOC

Breaking Bad: Reducing Glucose Variability and Increasing Time in Range in Patients with Diabetes

Begin

Learning Objectives:

• Explain and interpret current guidelines, consensus statements, and playbooks on time in range
• Discuss and evaluate strategies for the optimal use of diabetes technology in practice
• Value the significance of glucose variability and how to assess it

Credits:
1.5 AMA PRA Category 1 Credits™
1.5 ABIM MOC

Breaking the Cycle: Approaches to Long-Term Weight Loss and Obesity Care

Begin

Learning Objectives:

• Review and identify the available and emerging therapeutic approaches to obesity 
• Know what’s new in the obesity medicine pipeline 
• Review different approaches to weight loss/maintenance

Credits:
1.5 AMA PRA Category 1 Credits™
1.5 ABIM MOC

Blazing Ahead with Advances in the Management of Adult Growth Hormone Disorder

Begin

Learning Objectives:

• Identify aGHD based on presenting features and results of appropriate diagnostic tests 
• Assess characteristics of current and emerging aGHD treatment options to identify optimal individualized regimens based on patients’ clinical and personal characteristics
• Describe the available standard-of-care and emerging therapeutic approaches to address challenges of aGHD management, such as timely treatment initiation, treatment adherence, and therapeutic monitoring
• Discuss disease management challenges associated with transitioning pediatric patients with GHD to adulthood

Credits:
1.0 AMA PRA Category 1 Credits™
1.0 ABIM MOC

Severe Hypoglycemia: The Frequently Forgotten Threat

Begin

Learning Objectives:

• Better understand risks related to hypoglycemia
• Decrease the frequency and severity of hypoglycemia as an ADE among patients with T2D on insulin and/ or Sus who are identified as high risk
• Discuss the role of currently available pipeline methods to lower hypoglycemia risk

Credits:
1.5 AMA PRA Category 1 Credits™
1.5 ABIM MOC

Better Every Day: Improving Adherence and Quality of Life in Patients with Growth Hormone Deficiency

Begin

Learning Objectives:

• Summarize the epidemiological statistics and current best practices in growth hormone management
• Incorporate approaches to improve adherence from shared-decision making to appropriate use of longer-acting growth hormone formulations
• Counsel appropriate patients on benefits of GHD during the transition period

Credits:
1.0 AMA PRA Category 1 Credits™
1.0 ABIM MOC

All Eyes on Thyroid Eye Disease: A Master Clinician Discussion on Managing TED

Begin

Learning Objectives:

• Understand current medical and surgical options for moderate thyroid eye disease
• Apply the appropriate management for ophthalmic emergencies in thyroid eye disease
• Prioritize their approach to thyroid eye disease based on the different effects of currently available surgical and medical treatments on the different manifestations of TED

Credits:
1.0 AMA PRA Category 1 Credits™
1.0 ABIM MOC

Challenging Cases: When and How to Use GLP-1 Agonists in Diabetes Management

Begin

Learning Objectives:

• Apply guidelines and algorithms on the initiation and treatment of pharmacotherapies for the management of type 2 diabetes.
• Devise individualized initiation and treatment plans for patients with type 2 diabetes that incorporates updated clinical information on GLP-1 agonist options and take into consideration indications, safety, and efficacy as well as diabetes complications or significant risk factors.

Credits:
1.0 AMA PRA Category 1 Credits™
1.0 ABIM MOC

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline Educational Activity

Begin

Learning Objectives:

• Apply the clinical practice guideline recommendations for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes mellitus (T2DM) in individuals at metabolic risk for developing these conditions.

Credits:
.50 AMA PRA Category 1 Credits™

Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline Educational Activity

Begin

Learning Objectives:

• Diagnose central precocious puberty in male childhood cancer survivors exposed to gonadotoxic therapy.
• Explain how GH deficiency and central precocious puberty may occur together, making it difficult to interpret linear growth data.
• Diagnose non–GH-related causes of growth failure such as spinal irradiation.
• Accurately interpret thyroid function tests in patients at risk for primary and central hypothyroidism.
• Explain the importance of the synergistic action of GH and sex hormones in the growing adolescent.
• Explain the risk for exacerbation of the symptoms of adrenal insufficiency in individuals on thyroid replacement and untreated central adrenal insufficiency.

Credits:
0.5 AMA PRA Category 1 Credits™